• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Pin1 和 rho 信号转导伙伴的过表达与肝癌患者的转移行为和不良无复发生存相关。

Overexpression of Pin1 and rho signaling partners correlates with metastatic behavior and poor recurrence-free survival of hepatocellular carcinoma patients.

机构信息

Department of Surgery, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong.

Centre for Cancer Research, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong.

出版信息

BMC Cancer. 2019 Jul 19;19(1):713. doi: 10.1186/s12885-019-5919-3.

DOI:10.1186/s12885-019-5919-3
PMID:31324164
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6642482/
Abstract

BACKGROUND

Identification of molecular markers for early detection or prediction of metastasis is crucial for both management of HCC patient postoperative treatment and identify new therapeutic targets to inhibit HCC progression and metastasis. In the current study, we investigated the clinical correlation between Pin1, RhoA and RhoC and their association with HCC metastasis.

METHODS

Using a randomized study design of primary HCC samples from 139 patients, we determined messenger RNA expression of Pin1, RhoA and RhoC and their prognostic value.

RESULTS

Our findings demonstrated for the first time the clinical correlation of Pin1 in HCC metastasis. Pin1, RhoA and RhoC transcript levels were significantly higher in HCC specimens when compared with the paired adjacent non-tumorous liver. Pin1 overexpression was closely correlated with that of RhoA (R = 0.562, p < 0.001) and RhoC (R = 0.529, p < 0.001), and their co-overexpressions correlated with metastatic HCC (p = 0.000012) and poor recurrence-free survival of HCC patients (p < 0.00001), which showed better prognostic significance than either Pin1, RhoA or RhoC overexpression alone. Co-overexpressions of Pin1 + RhoA/RhoC were also an independent factor for predicting development of metastasis after curative resection in our multivariate regression model (p < 0.001).

CONCLUSION

Pin1, RhoA and RhoC co-overexpressions are prognostic factor for metastatic HCC and predict poor recurrence-free survival.

摘要

背景

识别用于早期检测或预测转移的分子标志物对于 HCC 患者术后治疗的管理以及确定抑制 HCC 进展和转移的新治疗靶点都至关重要。在本研究中,我们研究了 Pin1、RhoA 和 RhoC 与 HCC 转移之间的临床相关性及其与 HCC 转移的相关性。

方法

我们使用 139 名患者的原发性 HCC 样本的随机研究设计,确定了 Pin1、RhoA 和 RhoC 的信使 RNA 表达及其预后价值。

结果

我们的研究结果首次证明了 Pin1 在 HCC 转移中的临床相关性。与配对的相邻非肿瘤肝脏相比,HCC 标本中的 Pin1、RhoA 和 RhoC 转录水平显着升高。Pin1 的过表达与 RhoA(R=0.562,p<0.001)和 RhoC(R=0.529,p<0.001)的过表达密切相关,它们的共过表达与转移性 HCC(p=0.000012)和 HCC 患者无复发生存率差(p<0.00001)相关,其预后意义优于单独过表达 Pin1、RhoA 或 RhoC。Pin1+RhoA/RhoC 的共过表达也是我们多变量回归模型中预测根治性切除后转移发展的独立因素(p<0.001)。

结论

Pin1、RhoA 和 RhoC 的共过表达是转移性 HCC 的预后因素,并预测无复发生存率差。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cc1/6642482/c28f7a674916/12885_2019_5919_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cc1/6642482/bd88f005462e/12885_2019_5919_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cc1/6642482/c28f7a674916/12885_2019_5919_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cc1/6642482/bd88f005462e/12885_2019_5919_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cc1/6642482/c28f7a674916/12885_2019_5919_Fig2_HTML.jpg

相似文献

1
Overexpression of Pin1 and rho signaling partners correlates with metastatic behavior and poor recurrence-free survival of hepatocellular carcinoma patients.Pin1 和 rho 信号转导伙伴的过表达与肝癌患者的转移行为和不良无复发生存相关。
BMC Cancer. 2019 Jul 19;19(1):713. doi: 10.1186/s12885-019-5919-3.
2
Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer.Rho/ROCK信号通路与膀胱癌侵袭和转移的显著关联。
Clin Cancer Res. 2003 Jul;9(7):2632-41.
3
Loss of p57 expression and RhoA overexpression are associated with poor survival of patients with hepatocellular carcinoma.p57 表达缺失和 RhoA 过表达与肝癌患者的不良预后相关。
Oncol Rep. 2013 Oct;30(4):1707-14. doi: 10.3892/or.2013.2608. Epub 2013 Jul 9.
4
Elevated expression of autocrine motility factor receptor correlates with overexpression of RhoC and indicates poor prognosis in hepatocellular carcinoma.自分泌运动因子受体的高表达与RhoC的过表达相关,并提示肝细胞癌预后不良。
Dig Dis Sci. 2007 Mar;52(3):770-5. doi: 10.1007/s10620-006-9479-4.
5
Clinical and prognostic significance of RhoA and RhoC gene expression in esophageal squamous cell carcinoma.RhoA和RhoC基因表达在食管鳞状细胞癌中的临床及预后意义
Ann Surg Oncol. 2007 Dec;14(12):3593-601. doi: 10.1245/s10434-007-9562-x. Epub 2007 Sep 25.
6
[Overexpression of the RhoC gene correlates with invasion and metastasis of hepatocellular carcinoma].RhoC基因的过表达与肝细胞癌的侵袭和转移相关
Zhonghua Zhong Liu Za Zhi. 2004 May;26(5):279-82.
7
Overexpression of RhoA is associated with poor prognosis in hepatocellular carcinoma.RhoA的过表达与肝细胞癌的不良预后相关。
Eur J Surg Oncol. 2006 Dec;32(10):1130-4. doi: 10.1016/j.ejso.2006.05.012. Epub 2006 Jun 27.
8
[Expression of RhoC protein in human primary hepatocellular carcinoma and its clinical significance].[RhoC蛋白在人原发性肝细胞癌中的表达及其临床意义]
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2006 Jul;35(4):394-6. doi: 10.3785/j.issn.1008-9292.2006.04.009.
9
NGAL and NGALR overexpression in human hepatocellular carcinoma toward a molecular prognostic classification.NGAL 和 NGALR 在人肝癌中的过表达——一种分子预后分类。
Cancer Epidemiol. 2012 Oct;36(5):e294-9. doi: 10.1016/j.canep.2012.05.012. Epub 2012 Jun 23.
10
DLC-1 is an independent prognostic marker and potential therapeutic target in hepatocellular cancer.DLC-1是肝细胞癌中的一个独立预后标志物和潜在治疗靶点。
Diagn Pathol. 2016 Feb 4;11:19. doi: 10.1186/s13000-016-0470-x.

引用本文的文献

1
PIN1 promotes the metastasis of cholangiocarcinoma cells by RACK1-mediated phosphorylation of ANXA2.PIN1 通过 RACK1 介导的 ANXA2 磷酸化促进胆管癌细胞的转移。
Cell Oncol (Dordr). 2024 Aug;47(4):1233-1252. doi: 10.1007/s13402-024-00924-y. Epub 2024 Feb 22.
2
A novel immune-related gene signature predicts the prognosis of hepatocellular carcinoma.一种新型免疫相关基因特征可预测肝细胞癌的预后。
Front Oncol. 2022 Sep 15;12:955192. doi: 10.3389/fonc.2022.955192. eCollection 2022.
3
HSPB11 is a Prognostic Biomarker Associated with Immune Infiltrates in Hepatocellular Carcinoma.

本文引用的文献

1
International incidence and mortality trends of liver cancer: a global profile.全球肝癌发病率和死亡率趋势:国际概况。
Sci Rep. 2017 Mar 31;7:45846. doi: 10.1038/srep45846.
2
Osteopontin combined with CD44v6, a novel prognostic biomarker in non-small cell lung cancer undergoing curative resection.骨桥蛋白联合 CD44v6,一种非小细胞肺癌根治性切除术后新的预后生物标志物。
Ann Thorac Surg. 2013 Dec;96(6):1943-51. doi: 10.1016/j.athoracsur.2013.07.089. Epub 2013 Oct 3.
3
Loss of p57 expression and RhoA overexpression are associated with poor survival of patients with hepatocellular carcinoma.
HSPB11是一种与肝细胞癌免疫浸润相关的预后生物标志物。
Int J Gen Med. 2022 Apr 13;15:4017-4027. doi: 10.2147/IJGM.S363679. eCollection 2022.
4
Targeting Pin1 for Modulation of Cell Motility and Cancer Therapy.靶向Pin1调节细胞运动性及癌症治疗
Biomedicines. 2021 Mar 31;9(4):359. doi: 10.3390/biomedicines9040359.
5
Function of PIN1 in Cancer Development and Its Inhibitors as Cancer Therapeutics.PIN1在癌症发展中的作用及其抑制剂作为癌症治疗药物的研究
Front Cell Dev Biol. 2020 Mar 17;8:120. doi: 10.3389/fcell.2020.00120. eCollection 2020.
p57 表达缺失和 RhoA 过表达与肝癌患者的不良预后相关。
Oncol Rep. 2013 Oct;30(4):1707-14. doi: 10.3892/or.2013.2608. Epub 2013 Jul 9.
4
HBx and HBs regulate RhoC expression by upregulating transcription factor Ets-1.HBx 和 HBs 通过上调转录因子 Ets-1 来调节 RhoC 的表达。
Arch Virol. 2013 Aug;158(8):1773-81. doi: 10.1007/s00705-013-1655-1. Epub 2013 Mar 9.
5
Low expression of Beclin 1 and elevated expression of HIF-1α refine distant metastasis risk and predict poor prognosis of ER-positive, HER2-negative breast cancer.Beclin 1 低表达和 HIF-1α 高表达可细化 ER 阳性、HER2 阴性乳腺癌的远处转移风险,并预测不良预后。
Med Oncol. 2013 Mar;30(1):355. doi: 10.1007/s12032-012-0355-0. Epub 2013 Feb 14.
6
PIN1 inhibits apoptosis in hepatocellular carcinoma through modulation of the antiapoptotic function of survivin.PIN1 通过调节 survivin 的抗凋亡功能抑制肝癌细胞凋亡。
Am J Pathol. 2013 Mar;182(3):765-75. doi: 10.1016/j.ajpath.2012.11.034. Epub 2013 Jan 18.
7
Detection of miR-34a promoter methylation in combination with elevated expression of c-Met and β-catenin predicts distant metastasis of colon cancer.检测 miR-34a 启动子甲基化与 c-Met 和 β-连环蛋白的高表达相结合可预测结肠癌的远处转移。
Clin Cancer Res. 2013 Feb 1;19(3):710-20. doi: 10.1158/1078-0432.CCR-12-1703. Epub 2012 Dec 14.
8
HBV regulated RhoC expression in HepG2.2.15 cells by enhancing its promoter activity.HBV 通过增强其启动子活性调节 HepG2.2.15 细胞中的 RhoC 表达。
J Basic Microbiol. 2013 May;53(5):461-8. doi: 10.1002/jobm.201200063. Epub 2012 Jun 26.
9
Proteomic identification of RhoA as a potential biomarker for proliferation and metastasis in hepatocellular carcinoma.蛋白质组学鉴定 RhoA 作为肝癌增殖和转移的潜在生物标志物。
J Mol Med (Berl). 2011 Aug;89(8):817-27. doi: 10.1007/s00109-011-0753-3. Epub 2011 Apr 8.
10
HBx expression activates RhoA GTPase: impact on cell migration.HBx 表达激活 RhoA GTP 酶:对细胞迁移的影响。
Cell Biol Int. 2011 Feb;35(2):159-64. doi: 10.1042/CBI20100101.